ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 251 out of 682

$605K Total Retail Price of All Prescriptions

Rank: 241 out of 682

379 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 6,801 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 466 257 S3 1 1
LEVOTHYROXINE SODIUM 368 330 2 3
ZOLPIDEM TARTRATE 284 188 3 21
LISINOPRIL 264 212 4 2
FUROSEMIDE 237 182 5 7
HYDROCHLOROTHIAZIDE 211 184 6 12
SIMVASTATIN 160 134 7 4
METOPROLOL SUCCINATE 159 136 8 16
CITALOPRAM HBR 155 85 9 17
OMEPRAZOLE 146 76 10 5
CIPROFLOXACIN HCL 137 109 11 58
ATORVASTATIN CALCIUM 133 75 12 11
POTASSIUM CHLORIDE 126 109 13 14
METOPROLOL TARTRATE 121 102 14 10
AMLODIPINE BESYLATE 119 108 15 6
NEXIUM 117 104 16 19
METFORMIN HCL 116 86 17 8
GABAPENTIN 113 78 18 9
PREDNISONE 108 89 19 40
METHYLPREDNISOLONE 107 73 20 127
ALLOPURINOL 96 87 21 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 61 22 103
OXYCODONE HCL-ACETAMINOPHEN 82 23 S2 23 98
ATENOLOL 81 67 24 18
PRAVASTATIN SODIUM 79 69 25 15
AZITHROMYCIN 78 55 26 39
HUMULIN 70-30 78 50 26 229
CARVEDILOL 69 53 28 23
FLUOXETINE HCL 67 32 29 60
WARFARIN SODIUM 66 54 30 13
CEPHALEXIN 65 45 31 128
RANITIDINE HCL 63 40 32 28
AMITRIPTYLINE HCL 61 41 R 33 50
PANTOPRAZOLE SODIUM 60 34 34 29
CLOPIDOGREL 59 25 35 25
ALPRAZOLAM 59 20 35 90
SYNTHROID 58 55 37 59
INSULIN SYRINGE 57 36 38 75
AMOXICILLIN 57 43 38 113
TAMSULOSIN HCL 54 48 40 33
CRESTOR 54 54 40 22
CYMBALTA 53 51 42 51
VENTOLIN HFA 53 26 42 101
TRIAMTERENE-HCTZ 52 52 44 57
DIOVAN 51 39 45 42
NABUMETONE 51 47 45 227
GLYBURIDE 50 38 R 47 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.